Impact of Fc gamma receptor polymorphisms on efficacy and safety of daratumumab in relapsed/refractory multiple myeloma.
Niels W C J van de DonkTineke CasneufAlessandro Di CaraPaul W ParrenSonja ZweegmanBerris van KesselHenk M LokhorstSaad Z UsmaniSagar LonialPaul Gerard RichardsonChristopher ChiuTuna MutisInger S NijhofA Kate SasserPublished in: British journal of haematology (2018)